BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1715 related articles for article (PubMed ID: 11781648)

  • 21. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
    Fridkin SK; Kaufman D; Edwards JR; Shetty S; Horan T
    Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
    Colombo AL
    Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
    Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
    Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
    Luzzati R; Allegranzi B; Antozzi L; Masala L; Pegoraro E; Azzini A; Concia E
    Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
    Vigouroux S; Morin O; Moreau P; Harousseau JL; Milpied N
    Haematologica; 2006 May; 91(5):717-8. PubMed ID: 16670081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
    Hope W; Morton A; Eisen DP
    J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
    Minari A; Hachem R; Raad I
    Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
    Cohen Y; Karoubi P; Adrie C; Gauzit R; Marsepoil T; Zarka D; Clec'h C
    Crit Care Med; 2010 Mar; 38(3):826-30. PubMed ID: 20042858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
    Wingard JR; Merz WG; Rinaldi MG; Johnson TR; Karp JE; Saral R
    N Engl J Med; 1991 Oct; 325(18):1274-7. PubMed ID: 1669837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients.
    Tollemar J; Gross N; Dolgiras N; Jarstrand C; Ringdén O; Hammarström L
    Bone Marrow Transplant; 1999 Feb; 23(3):283-90. PubMed ID: 10084261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delay of onset of candidemia and emergence of Candida krusei fungemia in hematologic patients receiving prophylactic fluconazole.
    Jarque I; Saavedra S; Martin G; Pemán J; Pérez Bellés C; Sanz MA
    Haematologica; 2000 Apr; 85(4):441-3. PubMed ID: 10757896
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
    Nace HL; Horn D; Neofytos D
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
    Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
    Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II
    Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fluconazole consumption on long-term trends in candidal ecology.
    Blot S; Janssens R; Claeys G; Hoste E; Buyle F; De Waele JJ; Peleman R; Vogelaers D; Vandewoude K
    J Antimicrob Chemother; 2006 Aug; 58(2):474-7. PubMed ID: 16757503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple-species candidemia in patients with cancer.
    Boktour MR; Kontoyiannis DP; Hanna HA; Hachem RY; Girgawy E; Bodey GP; Raad II
    Cancer; 2004 Oct; 101(8):1860-5. PubMed ID: 15386338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
    Rimek D; Redetzke K; Kappe R
    Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 86.